Chimera Investment Corporation reports GAAP net loss of $0.27 per share for Q3 2025

Reuters
Nov 06
Chimera Investment Corporation reports GAAP net loss of $0.27 per share for Q3 2025

Chimera Investment Corporation reported a GAAP net loss of $0.27 per diluted common share for the third quarter ended September 30, 2025, and a GAAP net income of $1.67 per diluted common share for the nine months ended September 30, 2025. Earnings available for distribution were $0.37 per adjusted diluted common share. The company reported a GAAP book value of $20.2 per common share as of September 30, 2025. Economic return was (1.4)% for the quarter and 8.3% for the nine-month period. Total stockholders' equity was $2,571.2 million, and total liabilities and stockholders' equity reached $15,115.5 million. The company noted interest income from investment in MSR financing receivables of a consolidated VIE of $0.4 million for the quarter.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chimera Investment Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20251106679549) on November 06, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10